Cantrell Drug Company recalls MIDAZOLAM HCl in 0.9% Sodium Chloride Injection, 2 mg/2 mL (1 mg/mL), in 2 mL syringe, Rx only, Cantrell Drug Co., Litt…
- Recall date
- August 21, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1164-2016
- FDA classification
- Class II
- Brand / firm
- Cantrell Drug Company
- Sold / distributed
- Nationwide
Why it was recalled
Subpotent Drug
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
MIDAZOLAM HCl in 0.9% Sodium Chloride Injection, 2 mg/2 mL (1 mg/mL), in 2 mL syringe, Rx only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-001-16 UPC: 0100352533001161
Get recall alerts
Free email alert whenever Cantrell Drug Company has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Cantrell Drug Company